يعرض 1 - 20 نتائج من 92 نتيجة بحث عن '"Ko, Gyung-Hyuck"', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المساهمون: National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea, National Research Foundation of Korea, Republic of Korean government

    المصدر: European Journal of Surgical Oncology ; volume 46, issue 1, page 195-201 ; ISSN 0748-7983

  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal
  14. 14
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal

    وصف الملف: application/pdf

    Relation: Kwon, Oh Jin; Park, Jung Je; Ko, Gyung Hyuck; Seo, Ji Hyun; Jeong, Bae‐kwon; Kang, Ki Mun; Woo, Seung Hoon; Kim, Jin Pyeong; Hwa, Jeong Seok; Carey, Thomas E. (2015). "HIFâ 1α and CAâ IX as predictors of locoregional control for determining the optimal treatment modality for earlyâ stage laryngeal carcinoma." Head & Neck 37(4): 505-510.; https://hdl.handle.net/2027.42/110875; Head & Neck; Matsumoto M, Komiyama K, Okaue M, et al. Predicting tumor metastasis in patients with oral cancer by means of the proliferation marker Ki67. J Oral Sci 1999; 41: 53 – 56.; Jonathan RA, Wijffels KI, Peeters W, et al. The prognostic value of endogenous hypoxia‐related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 2006; 79: 288 – 297.; Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia‐inducible factor‐1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61: 2911 – 2916.; Zagórska A, Dulak J. HIF‐1: the knowns and unknowns of hypoxia sensing. Acta Biochim Pol 2004; 51: 563 – 585.; Kaluz S, Kaluzová M, Liao SY, Lerman M, Stanbridge EJ. Transcriptional control of the tumor‐ and hypoxia‐marker carbonic anhydrase 9: a one transcription factor (HIF‐1) show? Biochim Biophys Acta 2009; 1795: 162 – 172.; Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005; 202: 654 – 662.; Li DW, Zhou L, Jin B, Xie J, Dong P. Expression and significance of hypoxia‐inducible factor‐1α and survivin in laryngeal carcinoma tissue and cells. Otolaryngol Head Neck Surg 2013; 148: 75 – 81.; Ohba S, Fujii H, Ito S, et al. Overexpression of GLUT‐1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis. J Oral Pathol Med 2010; 39: 74 – 78.; Hui EP, Chan AT, Pezzella F, et al. Coexpression of hypoxia‐inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 2002; 8: 2595 – 2604.; Eriksen JG, Overgaard J; Danish Head and Neck Cancer Study Group (DAHANCA). Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study. Radiother Oncol 2007; 83: 383 – 388.; Lin PC, Lin YJ, Lee CT, Liu HS, Lee JC. Cyclooxygenase‐2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients. Oncol Lett 2013; 6: 733 – 739.; Morita Y, Hata K, Nakanishi M, Nishisho T, Yura Y, Yoneda T. Cyclooxygenase‐2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol 2012; 41: 885 – 892.; Park BW, Park S, Park HS, et al. Cyclooxygenase‐2 expression in proliferative Ki‐67‐positive breast cancers is associated with poor outcomes. Breast Cancer Res Treat 2012; 133: 741 – 751.; Atula T, Hedström J, Ristimäki A, et al. Cyclooxygenase‐2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. Oncol Rep 2006; 16: 485 – 490.; Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation‐associated human nuclear antigen defined by the monoclonal antibody Ki‐67. J Immunol 1984; 133: 1710 – 1715.; Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation‐associated nuclear antigen that is defined by monoclonal antibody Ki‐67. Am J Pathol 1991; 138: 867 – 873.; Liu M, Lawson G, Delos M, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head Neck 2003; 25: 280 – 288.; Koo TR, Eom KY, Kang EY, et al. Prognostic value of the nodal ratio and ki‐67 expression in breast cancer patients treated with postmastectomy radiotherapy. J Breast Cancer 2013; 16: 274 – 284.; Montebugnoli L, Badiali G, Marchetti C, Cervellati F, Farnedi A, Foschini MP. Prognostic value of Ki67 from clinically and histologically ‘normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study. Int J Oral Maxillofac Surg 2009; 38: 1165 – 1172.; Gonzalez–Moles MA, Ruiz–Avila I, Gil–Montoya JA, Esteban F, Bravo M. Analysis of Ki‐67 expression in oral squamous cell carcinoma: why Ki‐67 is not a prognostic indicator. Oral Oncol 2010; 46: 525 – 530.; Perisanidis C, Perisanidis B, Wrba F, et al. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med 2012; 41: 40 – 46.; Morais C, Johnson DW, Vesey DA, Gobe GC. Functional significance of erythropoietin in renal cell carcinoma. BMC Cancer 2013; 13: 14.; Henke M, Mattern D, Pepe M, et al. Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol 2006; 24: 4708 – 4713.; Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002; 7: 492 – 508.; Harrison LB, Shasha D, Homel P. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment. Oncology 2002; 63 Suppl 2: 11 – 18.; Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1–T2 glottic carcinomas. Cancer 2004; 100: 1786 – 1792.; Hosokawa Y, Okumura K, Terashima S, Sakakura Y. Radiation protective effect of hypoxia‐inducible factor‐1α (HIF‐1α) on human oral squamous cell carcinoma cell lines. Radiat Prot Dosimetry 2012; 152: 159 – 163.; Douglas CM, Bernstein JM, Ormston VE, et al. Lack of prognostic effect of carbonic anhydrase‐9, hypoxia inducible factor‐1α and bcl‐2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy. Clin Oncol (R Coll Radiol) 2013; 25: 59 – 65.; Rademakers SE, Hoogsteen IJ, Rijken PF, et al. Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial. Radiother Oncol 2013; 108: 517 – 522.; Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153 – 156.; Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994; 44: 7 – 26.; Vaupel P, Mayer A, Höckel M. Tumor hypoxia and malignant progression. Methods Enzymol 2004; 381: 335 – 354.; Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro‐regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003; 67: 3 – 15.; Rockwell S, Dobrucki IT, Kim EY, Marrison ST, Vu VT. Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med 2009; 9: 442 – 458.; Schrijvers ML, van der Laan BF, de Bock GH, et al. Overexpression of intrinsic hypoxia markers HIF1alpha and CA‐IX predict for local recurrence in stage T1‐T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 161 – 169.; Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Hypoxia‐activated tumor pathways of angiogenesis and pH regulation independent of anemia in head‐and‐neck cancer. Int J Radiat Oncol Biol Phys 2004; 59: 67 – 71.; Hirasawa N, Itoh Y, Naganawa S, et al. Multi‐institutional analysis of early glottic cancer from 2000 to 2005. Radiat Oncol 2012; 7: 122.; Moeller BJ, Richardson RA, Dewhirst MW. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 2007; 26: 241 – 248.; Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26: 225 – 239.; Vordermark D, Brown JM. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance? Strahlenther Onkol 2003; 179: 801 – 811.; Alvarez Marcos CA, Llorente Pendás JL, Franco Gutiérrez V, et al. Tumour recurrence in squamous head and neck cancer [in Spanish]. Acta Otorrinolaringol Esp 2007; 58: 156 – 163.

  20. 20
    Academic Journal